Ruxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallenge

Ann Hematol. 2015 Mar;94(3):519-20. doi: 10.1007/s00277-014-2183-0. Epub 2014 Aug 30.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antitubercular Agents / therapeutic use
  • Drug Administration Schedule
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects*
  • Nitriles
  • Polycythemia Vera / drug therapy
  • Primary Myelofibrosis / drug therapy*
  • Pyrazoles / administration & dosage*
  • Pyrazoles / adverse effects*
  • Pyrimidines
  • Tuberculosis, Lymph Node / chemically induced*
  • Tuberculosis, Lymph Node / drug therapy

Substances

  • Antitubercular Agents
  • Immunosuppressive Agents
  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib